Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Nicotine patches

Executive Summary

FDA's Drug Abuse Advisory Committee will address "pregnancy categories for nicotine-containing dosage units used for smoking cessation" at its July 14 meeting, agency announces in June 23 Federal Register. Recently-approved nicotine patches are currently pregnancy category D, carrying a warning against use in pregnant women who should be "encouraged to attempt cessation using educational and behavioral interventions before using pharmacological approaches." Marion Merrell Dow's Nicorette chewing gum is pregnancy category X, contraindicated in pregnant women. The meeting begins at 9 a.m. at the Holiday Inn Crowne Plaza in Rockville, Md.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS021109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel